logobest_018
Upcoming VCBH Events

Wednesday, May 15: VCBH Lecture Series featuring, Tim Lash, DSc, MPH
Time & Location: 12:00pm, UVM Davis Auditorium
Title: Significance Testing is the Reason that Scientific Results have Poor Reproducibility

Wednesday, June 26: VCBH Lecture Series featuring, Daniel Forman, MD
Time & Location: 12:00pm, UVM Davis Auditorium
Title: TBD

VCBH NIH Research Fellowship Opportunities

We are currently recruiting for two NIH Postdoctoral Fellowships.

Please visit our Career Opportunities page to learn more about these positions and to review the application instructions. 

Noteworthy

Assistant Professor, Andrea Villanti, PhD, MPH, participated in the University of Vermont (UVM) Community Medical School seminar series and spoke on the implications of non-combustible tobacco use. Her lecture titled, "Vaping, JUULing and E-cigarettes: Public Health Implications", is available to watch, here!

VCBH TCORS Postdoctoral Fellow, Maria Parker, PhD, receives a the highly competitive 2019 CPDD Travel Award for Early Career Investigators. Congratulations, Dr. Parker!

VCBH Director, Stephen Higgins, PhD, gave the inaugural lecture at the new University of Kansas Cofrin Logan Center for Addiction Research and Treatment. This Center, newly established in 2018, is directed and co-directed by Richard Yi, PhD, and Tera Fazzino, PhD, both of whom are post and predoctoral graduates of our T32 training program.

Tyler Nighbor, VCBH T32 Postdoc, publishes paper titled, "Examining Interrelationships Between the Cigarette Purchase Task and Delay Discounting" in the Journal of the Experimental Analysis of Behavior.

Stacey Sigmon, Ph.D. receives promotion to Tenured Associate Professor of Psychiatry and Psychological Sciences at the University of Vermont!

VCBH Research News

Villanti Partners with Vermont Department of Health to Launch PACE Study

PACE LogoAndrea Villanti, PhD, MPH, has partnered with the Vermont Department of Health (VDH) to launch the Policy and Communication Evaluation (PACE) study to understand the impact of state-level policies and communication campaigns on substance use beliefs and behaviors in young Vermonters. 

The study will enroll approximately 2,000 youth aged 12-17 and 1,000 young adults aged 18-25. Participants will completed three brief online surveys over a six-month period that included questions about tobacco, alcohol, and substance use beliefs and behaviors, awareness of and support for substance-related policies, and exposure to statewide tobacco substance use prevention initiatives.

Dr. Villanti and Christie Vallencourt with the VDH recently completed in interview discussing the study, with Vermont Public Radio. 

NIDA Notes features Sigmon's Research on Interim Buprenorphine during Treatment DelaysScreen Shot 2019-03-28 at 10.48.30 AM

NIDA Notes, an online news platform providing in-depth coverage of research findings on drug abuse and addiction, recently featured Stacey Sigmon's, PhD, work on interim treatment with buprenorphine for those awaiting treatment for opioid use disorder (OUD). VCBH predoctoral fellow, Ms. Joanna Streck, Dr. Sigmon, and colleagues developed and tested the interim treatment in a 12-week study. The prevalence of psychiatric disorders among those with OUD is very high, and this treatment has been shown to mitigate psychological distress in addition to reducing opioid use.

Dr. Sigmon notes, "It is exciting that providing just some basic pharmacotherapy and technology-assisted monitoring may attenuate psychiatric distress in this vulnerable group while they await more comprehensive treatment."

Ms. Streck was the first author on the manuscript summarizing the study findings.

Kurti Receives Prestigious APA Div 28 Award

Kurti_Allison (1)Allison Kurti, Ph.D., has received the 2019 American Psychological Association (APA) Div 28 Young Psychopharmacologist Award! This award honors a young scientist doing original, meritorious work in psychopharmacology and encourages excellence in research at the interface between the disciplines of pharmacology and psychology. Dr. Kurti was nominated for the award by VCBH Director, Stephen Higgins, PhD.

Dr. Kurti is excited and honored to receive this award, and is deeply appreciative of the opportunities and support that her mentors, colleagues, and peers have provided her, which she feels have put her in the position to receive this honor.

Sigmon Elected 2020-2021 CPDD President  Sigmon headshot crop[1]

Stacey Sigmon, PhD, has been elected as the 2020-2021 College of Problems on Drug Dependence (CPDD) President.  Dr. Sigmon is an Associate Professor with Tenure at the University of Vermont with the VCBH.  CPDD is the oldest and largest organization in the US dedicated to advancing a scientific approach to substance use and addictive disorders.  CPDD’s mission is to provide a national and international forum for scientists of diverse backgrounds to advance the understanding of molecular-neurobiological aspects of addictive disorders and, by the application of new scientific knowledge, to improve and develop treatments utilizing novel behavioral and pharmacological therapies.  Dr. Sigmon is a also current member of the CPDD Board of Directors and was the 2016 President for the American Psychological Association's Division on Psychopharmacology and Substance Use.  Congratulations, Dr. Sigmon!


Vermont Center on Behavior and Health Receives $30+ Million in Grant Renewals

Higgins PicUniversity of Vermont (UVM) Professor in the Departments of Psychiatry and Psychological Science, and Director of the Vermont Center on Behavior and Health (VCBH), Stephen T. Higgins, Ph.D., has announced the successful renewal of two multi-million dollar Center grants.

The Center of Biomedical Research Excellence (COBRE) award from the National Institutes of General Medical Sciences, and the Tobacco Center of Regulatory Science (TCORS) award from the National Institute on Drug Abuse and U.S. Federal and Drug Administration (FDA) will bring in over $30 million in federal funding to support another five years of research on the intersection of behavior and health, replicating what had been an unprecedented accomplishment at UVM when these two centers were first funded in September, 2013. 

The COBRE will continue its focus on increasing understanding of the mechanisms underpinning vulnerability to unhealthy behavior patterns and developing effective behavior-change interventions, with the end goal of establishing a productive, stand alone Center of research excellence. The TCORS will focus on a major policy under consideration by FDA's Center for Tobacco Products that would reduce the nicotine content of cigarettes below an addiction threshold.

Click here for the full press release on the COBRE and TCORS Awards!

VCBH/UVM Faculty & UVMMC Physicians Awarded SAMHSA Grant to Expand Medication Assisted Treatment for Opioid Use Disorder

University of Vermont (UVM) Faculty, Richard Rawson PhD, and Scott Mackey, PhD, along with University of Vermont Medical Center (UVMMC) Psychiatrist, Sanchit Maruti, MD, and Emergency Medicine Physician, Daniel Wolfson, MD, have been awarded a 3-year grant aimed at expanding medication assisted treatment (MAT) for opioid use disorder (OUD) in emergency departments (ED's) around the state.

The current practice of providing ED patients with OUD with a referral to treatment is often a missed opportunity to engage patients in MAT. Funded by the Substance Abuse and Mental Health Services Administration (SAMHSA), this grant will allow three Vermont medical centers the opportunity to establish a new intervention to initiate treatment for those presenting with OUD at the ED, then transfer these patients to a community treatment center.

Principal Investigators, Drs. Mackey, Maruti, and Wolfson, will lead the study and Dr. Rawson will act as the evaluator to determine the effectiveness of initiating treatment in this setting.

Screen Shot 2018-11-05 at 3.25.59 PMPublished: Preventive Medicine Fifth Special Issue, December 2018

The December 2018 Special Issue of Preventive Medicine (PM) is the fifth in a series that focuses on behavior change, health, and health disparities. Contributors to these Special Issues are selected from participants in the 2017 VCBH 5th Annual Conference on Tobacco Regulatory Science.

The topics covered in this Special Issue are specific to tobacco regulatory science, a field which assures that the Food and Drug Administration's (FDA) Center of Tobacco Products (CTP) has the multidisciplinary scientific input necessary to conduct evidence-based regulation. More specifically, this issue focuses on a set of three current topics in tobacco regulatory science:

1) Examining current research examining the effects of a potential national policy that would reduce the nicotine levels in cigarettes to minimally addictive levels.

2) Increasing scientific understanding on the risk and patterns of cigarette smoking and other tobacco use in vulnerable populations.

3) Potential role of e-cigarettes and other non-combusted sources of nicotine as less harmful substitutes for combusted products for those unwilling or unable to quite nicotine use.

GaalemasmallGaalema Receives NIH Award Examining Interventions to Increase Cardiac Rehabilitation Participation Among Low-SES Patients

Diann Gaalema, Ph.D., has received funding for an NIH-sponsored R61 award that will examine the efficacy of using early case management and financial incentives for increasing cardiac rehabilitation (CR) participation among lower socioeconomic status (SES) patients. Participation in outpatient CR has shown to decrease morbidity and mortality for patients hospitalized with for various heart conditions. However, only 10-35% of patients for whom CR is recommended, choose to participate. Low-SES is a strong indicator of non-CR participation, therefore there is a strong need to increase CR participation within this population. Both case management and financial incentives are proven effective in altering behaviors and promoting adherence to health-related regimens.

Dr. Gaalema is a graduate of the VCBH Project Director mentoring program in which she successfully completed a randomized clinical trial studying the effects of financial incentives to increase CR participation among disadvantaged populations. Her new award will allow her to continue her research in this field to increase awareness about the efficacy and cost-effectiveness of such approaches that have the potential to substantially increase CR participation and improve health outcomes among lower-SES cardiac patients. 

Image of YIR cover

 
Click here to read the 2017-2018 VCBH Year in Review.